News

New Terms Announced in XOMA Royalty and LAVA Agreement

New Terms Announced in XOMA Royalty and LAVA Agreement

Recent Amendments to the XOMA Royalty and LAVA Therapeutics Agreement

In a significant development within the biotech sector, XOMA Royalty Corporation (NASDAQ: XOMA) and LAVA Therapeutics N.V. (NASDAQ: LVTX) have reached an agreement to amend the terms of their previously established purchase agreement. This amendment revises the financial components crucial for LAVA shareholders.

Details of the Amendment

The amendment stipulates that LAVA shareholders who choose to tender their shares will receive an initial cash amount of $1.04 per share. This new cash amount is a revision from the prior agreement, which had set the range between $1.16 and $1.24. In addition to this cash compensation, shareholders will also be entitled to a non-transferable contingent value right (CVR). This CVR could yield further cash payments based on net proceeds from LAVA's partnered and unpartnered projects.

Revised Closing Conditions

Another key aspect of the amendment is the adjustment of LAVA's minimum net-cash closing condition, which has been decreased to $24.5 million from the previous $31.5 million. This revision comes as both companies reassess their financial landscapes and expected cash balances. This strategic change allows for increased flexibility during the completion of the acquisition.

Extension of Offer Duration

The offer, which initially had an expiration set for a specific time in October, has now been extended until November. This extension is crucial, allowing more time for potential participants to tender their shares without the need for re-tendering actions. LAVA shareholders have previously mobilized their intent to support the offer, making this extension a strategic decision to secure more robust participation.

Conditions for Closing the Offer

The fulfillment of this offer is contingent upon several conditions, including tendering a significant percentage of LAVA common shares and the adoption of certain resolutions during a shareholder meeting. This meeting will play a pivotal role in the approval of transactions between LAVA and XOMA Royalty.

Extraordinary General Meeting Scheduled

To facilitate shareholder approval, LAVA intends to hold an extraordinary general meeting to address vital matters concerning the partnership with XOMA Royalty. This meeting will occur at a newly determined time, with the venue situated at NautaDutilh N.V. in Amsterdam. This meeting bears importance not only for reviewing the agreement but also for shaping the future strategic direction of both companies.

About XOMA Royalty Corporation

XOMA Royalty plays a crucial role in the biotech industry as a royalty aggregator, supporting emerging companies in realizing their potential to enhance human health. By acquiring future economic rights linked to therapeutic candidates, XOMA Royalty provides non-dilutive funding that companies can utilize for developmental purposes.

About LAVA Therapeutics

LAVA Therapeutics is pioneering the field of biopharmaceuticals with its innovative bispecific gamma delta T cell engagers, showcasing a robust pipeline aimed at treating various cancers. Its collaboration with major pharmaceutical firms highlights the potential of its proprietary technologies to address significant healthcare challenges.

Frequently Asked Questions

What are the main changes in the amended agreement?

The cash amount per share has been revised to $1.04, and the minimum net cash condition has been lowered to $24.5 million.

When is the new date for the extraordinary general meeting?

The extraordinary general meeting is scheduled for November 7, 2025, at 2:00 p.m. Central European Summer Time.

How does the contingent value right (CVR) work?

The CVR entitles shareholders to additional cash payments based on the net proceeds from LAVA's partnered and unpartnered assets.

What is XOMA Royalty's role in the agreement?

XOMA Royalty serves as the acquirer of future economic rights from LAVA, enabling financial support for its ongoing projects.

How can shareholders participate in the tender offer?

Shareholders can participate by tendering their shares according to the amended agreement's terms, now extended until November 12, 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 120

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 114

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 108

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 104

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Surf City Seasons Put Vacation Rental Timing in Focus

Updated Category News Views 42

Summer’s Calendar Does the Talking School bells, not seagulls, appear to set the pace for Surf City’s rental market. Chris Rackley’s seasonal guide makes a pretty grounded point: the “best” time to visit Surf City, North Carolina, is not some universal magic week on a postcard. It depends on whether a traveler needs peak beach weather, wants elbow room, or...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitfarms and Riot Platforms Reach Important Settlement Agreement

Updated Category News Views 57

Bitfarms Ltd and Riot Platforms Reach Settlement on Disputes Today, Bitfarms Ltd (NASDAQ:BITF), a leading player in the cryptocurrency mining field, announced that it has successfully settled disputes with Riot Platforms (NASDAQ:RIOT). This important settlement seeks to resolve various conflicts that existed between the two companies, although the specific details of...

Continue Reading
Peer To Peer Network Unveils Strategic Insights for PTOP Labs

Updated Category News Views 195

Peer To Peer Network Reveals Insights on PTOP Intelligence Labs Peer To Peer Network (OTC: PTOP) has taken a decisive step towards revolutionizing investor communication and engagement with the introduction of PTOP Intelligence Labs. During a recent call, the company’s newly appointed division president, Derek McCarthy, shared insights into the innovative AI-driven...

Continue Reading
Firsthand Technology Fund Reports Third Quarter Financial Performance

Updated Category News Views 234

Firsthand Technology Value Fund Financial Overview Firsthand Technology Value Fund, Inc. (OTCQB: SVVC), a publicly trading venture capital fund focused on technology and cleantech investments, has provided an update on its financial performance for the recent quarter. As of the end of September, the Fund reported net assets amounting to $296,547, translating to $0.04 per...

Continue Reading
Nanit Unveils Innovative AI Sleep Score Tailored for Babies

Updated Category News Views 310

Nanit Launches Groundbreaking AI Sleep Score for Infants Nanit has introduced an innovative Sleep Score feature aimed specifically at helping parents enhance their babies' sleep quality. This groundbreaking technology translates complex clinical-grade sleep data into a single, easy-to-understand number. Parents will now have access to a powerful tool that demystifies...

Continue Reading
The Surge of the Manufacturing Execution System Market

Updated Category News Views 155

Introduction to the Manufacturing Execution System Market The global manufacturing execution system (MES) market is experiencing remarkable growth, fueled by the rising trend of digital transformation across various manufacturing sectors. As industries evolve, the demand for real-time data and efficient management of production processes is becoming increasingly critical....

Continue Reading